Form 4 for IRON Disc Medicine, Inc.
Accepted 2023-09-05 00:00:00 ET · period of report 2023-09-01 · accession 0000950170-23-046397 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2023-09-05 | 2023-09-01 | IRON | Bryce Joanne | CFO | S - Sale+OE | $52.99 | -1,000 | 1,260 | -44% | -$53.0K |
| DT | 2023-09-05 | 2023-09-01 | IRON | Bryce Joanne | CFO | M - OptEx | $2.65 | +1,000 | 2,260 | +79% | +$2,650 |
| DT | 2023-09-05 | 2023-09-01 | IRON | Bryce Joanne | CFO | M - OptEx | $0.00 | -1,000 | 3,753 | -21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-01 | S | D | 1,000 | $52.99 | 1,260 | D | — | — | |
| 2 | Common | Common Stock | 2023-09-01 | M | A | 1,000 | $2.65 | 2,260 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-09-01 | M | D | 1,000 | $0.00 | 3,753 | D | $2.65 · — to 2030-10-22 | 1,000 Common Stock | (F2) The shares underlying this option vest in 48 equal monthly installments following October 7, 2020, subject to the Reporting Person's continued service on each such vesting date. |